Ayble Health Raises $16M for Virtual Digestive Care

Ayble Health has closed a $16 million Series A to build out its virtual clinic for digestive conditions, MedCity News reports. The round was led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx and Accomplice.

Ayble targets chronic gastrointestinal problems such as irritable bowel syndrome and inflammatory bowel disease, combining nutrition therapy, behavioral health support and clinical care delivered remotely. Digestive disorders affect tens of millions of Americans and often go undermanaged, leaving room for specialized virtual programs that coordinate diet, symptom tracking and provider access in one place.

The raise reflects continued investor appetite for condition-specific digital clinics that promise measurable outcomes and cost savings to employers and payers. The presence of Cleveland Clinic Ventures signals health-system interest in the model. For Ayble, the capital funds growth as it competes for enterprise contracts and works to prove that virtual GI care can reduce costly specialist visits and procedures.